Daniel Woolson - Mar 6, 2023 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Role: VP, GM-Infusion Capital
Signature: By: Paula Darbyshire, Attorney-in-fact For: Daniel Woolson
Stock symbol: ICUI
Transactions as of: Mar 6, 2023
Transactions value $: -$307,956
Form type: 4
Date filed: 3/8/2023, 04:09 PM
Previous filing: Feb 2, 2023
Next filing: Dec 1, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ICUI	Common Stock	Options Exercise	$0	+1.42K	+15.48%	$0.00	10.6K	Mar 6, 2023	Direct
transaction	ICUI	Common Stock	Tax liability	-$101K	-626	-5.92%	$161.25	9.94K	Mar 6, 2023	Direct
transaction	ICUI	Common Stock	Options Exercise	$0	+965	+9.71%	$0.00	10.9K	Mar 7, 2023	Direct
transaction	ICUI	Common Stock	Tax liability	-$67.4K	-428	-3.92%	$157.47	10.5K	Mar 7, 2023	Direct
transaction	ICUI	Common Stock	Options Exercise	$0	+2.02K	+19.27%	$0.00	12.5K	Mar 8, 2023	Direct
transaction	ICUI	Common Stock	Tax liability	-$140K	-894	-7.15%	$156.17	11.6K	Mar 8, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ICUI	Common Stock	Options Exercise	$0	-965	-33.31%	$0.00	1.93K	Mar 7, 2023	Common Stock	965	$0.00	Direct	F1, F2, F3, F4
transaction	ICUI	Performance Shares	Options Exercise	$0	-2.02K	-50%	$0.00	2.02K	Mar 8, 2023	Common Stock	2.02K	$0.00	Direct	F5, F6
transaction	ICUI	Performance Shares	Options Exercise	$0	-1.42K	-100%	$0.00^*	0	Mar 6, 2023	Common Stock	1.42K		Direct	F5, F7, F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are Restricted Stock Units.
F2	There is neither a purchase price nor an exercise price for the Restricted Stock Units.
F3	One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
F4	These are restricted stock units that fully vest 3 years from the grant date.
F5	These Securities are Performance-based Restricted Stock Units (PRSU).
F6	These PRSUs were granted on March 8, 2021. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 8 of the first, second, and third year following the year of grant.
F7	There is neither a purchase price nor an exercise price for the PRSUs.
F8	These PRSUs were granted on March 6, 2020. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant.